efavirenz and Acquired Immune Deficiency Syndrome

efavirenz has been researched along with Acquired Immune Deficiency Syndrome in 120 studies

Research

Studies (120)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	13 (10.83)	18.2507
2000's	61 (50.83)	29.6817
2010's	40 (33.33)	24.3611
2020's	6 (5.00)	2.80

Authors

Authors	Studies
Balzarini, J; Barreca, ML; Chimirri, A; De Clercq, E; De Luca, L; Iraci, N; Maga, G; Monforte, AM; Pannecouque, C; Rao, A	1
Cabrera, SE; Domínguez-Gil, A; García, MJ; González, F; Luna, G; Santos, D; Valverde, MP	1
Burt, C; Corbau, R; Gayton, S; Hawes, M; Mowbray, CE; Perros, M; Price, DA; Quinton, FJ; Selby, MD; Stupple, PA; Tran, I; Webster, R; Wood, A	1
Adimora, AA; Althoff, KN; Cole, SR; Edwards, JK; Eron, JJ; Gebo, K; Gill, MJ; Horberg, MA; Hudgens, MG; Jetsupphasuk, M; Kitahata, MM; Lang, R; Lima, VD; Lu, H; Marconi, VC; Moore, RD; Rabkin, C; Rebeiro, PF; Silverberg, MJ; Sterling, TR	1
Cardoso, SW; Cunha, CB; Grinszteijn, B; Portela, EN; Reis, AO; Rocco Suassuna, JH; Veloso, VG	1
Chen, Y; Fu, G; Huang, X; Li, L; Li, Q; Li, Y; Ma, P; Qiao, Y; Su, B; Wang, H; Wang, L; Wang, R; Wu, G; Wu, X; Xin, X; Xu, J; Yang, Y; Zhang, T; Zou, H	1
Gadhave, D; Khandekar, G; Kokare, C; Koli, D; Mote, C	1
Li, A; Li, C; Li, H; Li, W; Li, X; Xia, W	1
Ângelos, MA; da Silva, RMF; de Freitas Neto, JL; de Melo, CG; do Nascimento Gomes Barbosa, I; Dos Santos Mendes, LM; Ferreira, MRA; Neto, PJR; Rolim, LA; Soares, LAL	1
Brookhart, MA; Cole, SR; Crane, HM; Edwards, JK; Eron, JJ; Hall, HI; Kitahata, MM; Mathews, WC; Moore, RD; Mugavero, MJ; Saag, MS	1
Abgrall, S; Arribas, JR; Barger, D; Barrufet, P; Braun, D; Caniglia, EC; Cardoso, SW; Chrysos, G; Costagliola, D; Gill, J; Gogos, C; Hauser, C; Hernán, MA; Hoyos, SP; Justice, A; Leyes, M; Lodi, S; Logan, R; Meyer, L; Moreno, S; Muga, R; Pacheco, A; Phillips, A; Porter, K; Reiss, P; Sabin, CA; Seng, R; Tate, J; van Sighem, A; Vandenhende, MA; Winston, A	1
Amariles, P; Castañeda, C; Galindo, J; Mueses-Marín, HF	1
Alobwede, SM; Kongnyuy, EJ; Shey, MS; Wiysonge, CS	1
Dandara, C; Ren, Y; Skelton, M; Smith, P; Swart, M; Takuva, S	1
Ashton, M; Bienvenu, E; Hoffmann, KJ; Kayumba, PC	1
Cortes, CP; Otto-Knapp, R; Saavedra, F; Weitzel, T; Wolff, M	1
Aghokeng, AF; Chia, JE; Delaporte, E; Einterz, E; Eymard-Duvernay, S; Molina, JM; Mpoudi-Ngole, E; Peeters, M; Taieb, F	1
Holla, P; Jameel, S; Munshi, SU; Panda, H; Rewari, BB	1
Arnedo, M; Domingo, P; Egaña-Gorroño, L; Escribà, T; Fontdevila, J; Gatell, JM; Loncà, M; Martínez, E; Negredo, E; Vidal, F	1
Cai, W; Ding, T; Dong, P; Lu, H; Meng, X; Shen, L; Yin, K; Zhang, L; Zhang, R	1
Daar, ES; de Bakker, PI; Gulick, RM; Haas, DW; Haubrich, RH; Lehmann, DS; McLaren, PJ; Ribaudo, HJ; Robbins, GK	1
Fan, P; Li, J; Li, N; Liang, Y; Ma, Y; Sun, D; Wang, Z; Yang, W; Zhu, Q	1
Chonzi, P; Dhoro, M; Kadzirange, G; Masimirembwa, C; Ngara, B; Nhachi, C; Zvada, S	1
Hurkat, P; Jain, A; Jain, SK; Vyas, A	1
Acosta, EP; Daar, ES; Haas, DW; Li, C; Morse, GD; Shepherd, BE; Venuto, C; Wanga, V	1
Mariana, N; Rusli, A	1
Acosta-Gio, AE; Aquino-García, SI; Ceballos-Salobreña, A; Gaitán-Cepeda, LA; Rivas, MA	1
Arribas, JR; Bellos, NC; Bernstein, BM; Brun, SC; Cameron, DW; da Silva, BA; Gilmore, N; Hanna, GJ; King, MS; Myers, RA	1
Botterel, F; Bretagne, S; Hadji, C; Huet, E; Hulin, A; Lévy, Y	1
Djoerban, Z; Sumantri, S	1
Cohn, S; Currier, J; Koletar, S; McCutchan, J; Murphy, R; Williams, P; Wu, J	1
Carbonara, S; Ciracì, E; Cusato, M; Heichen, M; Monno, L; Regazzi, M; Stano, F; Villani, P	1
Chan, DP; Chan, RC; Cheung, SW; Lee, SS; Liu, ST; To, KW	1
Dieng, AB; Diop, BM; Diop, SA; Diouf, A; Fall, MB; Lakh, A; Ndiaye, I; Niang, Kh; Seydi, M; Soumaré, M; Sow, A; Sow, PS; Tekpa, G	1
Kongnyuy, EJ; Shang, J; Shey, M; Wiysonge, CS	1
Lavae-Mokhtari, M; Mohammad-Khani, S; Schmidt, RE; Stoll, M	1
Gulick, RM; Kmack, A; Krambrink, A; Kuritzkes, DR; Ribaudo, HJ; Schouten, JT; Shikuma, C; Webb, N	1
Abzug, MJ; Brogly, SB; Conway, D; Cunningham, CK; Oleske, J; Sperling, RS; Spiegel, H; Van Dyke, RB; Watts, DH; Williams, PL	1
Hill, CJ; Hsu, O; Kim, M; O'Brien, JG; Tan, B	1
Dhlomo, S; Emery, S; Grandits, G; Khabo, P; Khanyile, T; Komati, S; Magongoa, D; Naidoo, LC; Neaton, JD; Polis, M; Qolohle, D; Ratsela, A	1
Chiappetta, DA; de Celis, ER; Facorro, G; Sosnik, A	1
Honda, M; Ishisaka, M; Ishizuka, N; Kimura, S; Oka, S	1
Beauharnais, CA; Dillingham, R; Dupnik, K; Eyma, E; Fitzgerald, D; Guerrant, R; Jennings, S; Kashuba, A; Leger, P; Miller, E; Pape, J; Samie, A	1
Aklillu, E; Ashton, M; Gustafsson, LL; Mukonzo, JK; Nanzigu, S; Ogwal-Okeng, J; Rekić, D; Röshammar, D; Waako, P	1
Andrade-Villanueva, J; Boven, K; Clotet, B; Cohen, CJ; Crauwels, H; Fourie, J; Johnson, MA; Rimsky, LT; Ruxrungtham, K; Vanveggel, S; Wu, H; Zorrilla, C	1
Boven, K; Cahn, P; Crauwels, H; Grinsztejn, B; Lazzarin, A; Mills, A; Molina, JM; Rimsky, LT; Saag, M; Supparatpinyo, K; Vanveggel, S; Walmsley, S	1
Donnelly, J	1
Canter, JA; Grady, BJ; Haas, DW; Hulgan, T; Kalams, SA; Murdock, DG; Pollard, RB; Ritchie, MD; Robbins, GK; Samuels, DC; Selph, D; Shafer, R	1
Bussmann, H; deGruttola, V; Marlink, RG; Stitelman, OM; van der Laan, MJ; Wester, CW	1
Arends, J; Hoepelman, A; Mudrikova, T; Van Welzen, B	1
Arasteh, K; Boven, K; Crauwels, H; De Wet, J; Gathe, J; Gold, J; Hodder, S; Kumar, P; Mohapi, L; Short, W; Vanveggel, S	1
Bloom, A; Brown, TT; Daar, ES; Fedarko, N; Ha, B; Jahed, NC; Kitch, D; McComsey, GA; Melbourne, K; Sax, PE; Tierney, C	1
Shanske, AL	1
Carda-Broch, S; Casas-Breva, I; Esteve-Romero, J; Peris-Vicente, J; Rambla-Alegre, M	1
Anastos, K; Aouizerat, BE; Cohen, M; Conti, DV; De Hovitz, J; Frasco, MA; Golub, ET; Greenblatt, RM; Liu, C; Mack, WJ; Pearce, CL; Van Den Berg, D	1
Lu, HZ; Shen, YZ; Wang, ZY	1
Dandara, C; Ramesar, RS; Ren, Y; Smith, P; Swart, M; Whitehorn, H	1
Bonafede, M; Correll, T; Hebden, T; Juday, T; Lenhart, G; Pan, K	1
Arribas, JR; Costa, MA; Del Palacio, A; Gatell, JM; González, J; Lonca, M; Lorenzo, A; Miró, JM; Peña, JM; Pulido, F; Rubio, R; Torralba, M; Vázquez, JJ	1
Flexner, C; Gandhi, R	1
Cohen, MS; Eron, JJ; Fiscus, SA; Fiske, WD; Gotzkowsky, SK; Kashuba, AD; Kim, JY; Petch, L; Reddy, YS	1
Abrescia, N; Busto, A; Butrico, E; D'Abbraccio, M; De Marco, M; Figoni, M; Viglietti, R	1
Bennett, KK; Hammer, SM; Labbé, L; Mellors, J; Pfister, M; Rosenkranz, S; Sheiner, LB	1
Bowonwatanuwong, C; Chantratita, W; Chetchotisakd, P; Mootsikapun, P; Sungkanuparph, S; Tansuphaswaswadikul, S; Vibhagool, A	1
Clerici, M; Ferrante, P; Havlir, DV; Ignacio, C; Strain, MC; Trabattoni, D; Wong, JK	1
Aarnoutse, RE; Boyd, MA; Burger, DM; Cooper, DA; Lange, JM; Phanuphak, P; Ruxrungtham, K; Stek, M; van Heeswijk, RP	1
Bassett, R; Currier, JS; DeGruttola, V; Demeter, LM; Eron, JJ; Fischl, MA; Hammer, SM; Mellors, JW; Morse, GD; Santana, JL; Squires, KE	1
Arendt, G; Haslinger, BA	1
Ahmad, K	1
Acosta, EP; Clifford, DB; Gulick, RM; Haas, DW; Hulgan, T; Kim, RB; Marzolini, C; Ribaudo, HJ; Tierney, C; Wilkinson, GR	1
Burger, D; Clotet, B; Ferrer, MJ; Fumaz, CR; Gómez, G; Moltó, J; Muñoz-Moreno, JA; Negredo, E; Pérez-Alvarez, N; Sirera, G	1
Bergshoeff, AS; Burger, DM; De Groot, R; Fraaij, PL; Hartwig, NG; Ndagijimana, J; Niehues, T; Verweel, G	1
Brunet, M; Gallart, T; García, F; Gatell, JM; Martorell, J; Millán, O; Miró, JM; Plana, M; Pumarola, T; Rojo, I; Vidal, E	1
Franklin, P; Hull, AD; Saitoh, A; Spector, SA	1
Barbosa-Sicard, E; Eichelbaum, M; Klein, K; Lang, T; Saussele, T; Schunck, WH; Schwab, M; Zanger, UM	1
Bautista-Arredondo, S; Bertozzi, SM; Mane, A	1
Acosta, EP; Clifford, DB; Fletcher, CV; Gulick, RM; Haas, DW; Kim, RB; Kuritzkes, DR; Marzolini, C; Ribaudo, HJ; Tashima, KT; Tierney, C; Wilkinson, GR	1
De Nicola, M; Ghibelli, L; Lichtner, M; Mastroianni, CM; Mengoni, F; Rossi, R; Sauzullo, I; Vullo, V	1
Arlotti, M; Bongiovanni, M; Cauda, R; Cozzi-Lepri, A; De Luca, A; Di Giambenedetto, S; Lichtner, M; Mena, M; Moioli, MC; Monforte, Ad; Narciso, P; Phillips, AN; Sighinolfi, L	1
Mitsuya, H	1
Clifford, DB; D'Aquila, RT; Donahue, JP; Haas, DW; Hirsch, MS; Johnson, VA; Kim, RB; Labbe, L; Merigan, TC; Morse, GD; Motsinger, AA; Pollard, RB; Ritchie, MD; Robbins, GK; Shafer, RW; Wilkinson, GR	1
Bassetti, M; De Maria, A; Dentone, C; Di Biagio, A; Parodi, A; Rosso, R; Viscoli, C	1
Asiimwe, F; Behumbiize, P; Brooks, JT; Forna, F; Liechty, CA; Mermin, J; Solberg, P; Tong, T; Weidle, PJ; Were, W	1
Lange, JM; van Leth, F; Wit, FW	1
Bockarie, MJ; Mehlotra, RK; Zimmerman, PA	1
Andrade, RA; Hamill, RJ; Koo, HL	1
Antinori, A; Baxter, J; Cauda, R; Clevenbergh, P; Colafigli, M; De Luca, A; Giambenedetto, SD; Perno, CF; Prosperi, M; Ruiz, L; Trotta, MP	1
Ashton, M; Chigutsa, E; Chonzi, P; Masimirembwa, C; Nhachi, C; Nyakutira, C; Röshammar, D	1
Bessen, L; Nelson, M; Overfield, S; Rachlis, A; Ruiz, N; Skiest, D; Staszewski, S; Stryker, R; Tashima, K; Wirtz, V	1
Cheng, J; Han, N; Liu, YN; Liu, ZY; Wei, HS; Zhang, FJ; Zhao, HX; Zhao, Y	1
Borkowf, CB; Brooks, JT; Buchacz, K; Downing, R; Kigozi, A; Mermin, J; Moore, D; Ndazima, V; Weidle, PJ; Were, W	1
Elliott, EB	1
Baggett, TH; Gracia Jones, S	1
Ahmad, M; Brennan, JM; Caliendo, AM; Fiske, WD; Flanigan, TP; Gormley, JM; Tashima, KT	1
Gatell, JM; Martínez, E	1
Ruiz, N	1
Staszewski, S	1
Baldwin, C; Moyle, G	1
Caro, JJ; Migliaccio-Walle, K; O'Brien, JA; Raggio, G	1
Lasso, M; Noriega, LM; Northland, R; Pérez, J	1
James, JS	1
Baker, R	1
Gilden, D	1
Agosto, M	1
Morse, A; Welch, KJ	1
Abrescia, N; Cozzi-Lepri, A; d'Arminio Monforte, A; Leoncini, F; Moroni, M; Orani, A; Petrosillo, N; Phillips, AN; Piersantelli, N; Scerbo, A; Tundo, P	1
Campiani, G; Catalanotti, B; Fattorusso, C; Maga, G; Morelli, E; Nacci, V; Novellino, E; Ramunno, A	1

Reviews

8 review(s) available for efavirenz and Acquired Immune Deficiency Syndrome

Article	Year
Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS. The Cochrane database of systematic reviews, 2013, Mar-28, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Combinations; HIV Infections; Humans; Lamivudine; Nelfinavir; Oligopeptides; Pyridines; Randomized Controlled Trials as Topic; Zidovudine	2013
Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols. Pharmacogenetics and genomics, 2015, Volume: 25, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Therapy, Combination; Genome-Wide Association Study; HIV Infections; HIV-1; Humans; Polymorphism, Single Nucleotide; Randomized Controlled Trials as Topic; Treatment Outcome	2015
A combination drug of abacavir-lamivudine-zidovudine (Trizivir) for treating HIV infection and AIDS. The Cochrane database of systematic reviews, 2009, Jul-08, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Drug Combinations; HIV Infections; Humans; Lamivudine; Nelfinavir; Oligopeptides; Pyridines; Randomized Controlled Trials as Topic; Zidovudine	2009
Bilateral oblique facial clefts and extremity anomaly in an infant after intrauterine efavirenz exposure and review of its teratogenic risk. AIDS (London, England), 2012, Sep-10, Volume: 26, Issue:14 Topics: Abnormalities, Drug-Induced; Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Child of Impaired Parents; Cleft Palate; Craniofacial Dysostosis; Cyclopropanes; Eye Abnormalities; Female; Humans; Imaging, Three-Dimensional; Infant; Infant, Newborn; Maxillofacial Abnormalities; Pregnancy; Prenatal Exposure Delayed Effects; Radiography; Teratogens	2012
[Progress in AIDS therapy]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2006, Sep-10, Volume: 95, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Clinical Trials as Topic; Cyclopropanes; Drug Design; Drug Resistance, Viral; HIV Integrase Inhibitors; Humans; Imidazoles; Oxazines; Protease Inhibitors; Reverse Transcriptase Inhibitors; Sulfoxides; Zidovudine	2006
Clinical update: new drugs for HIV/AIDS. Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses, 1999, Volume: 8, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Carbamates; Chemistry, Pharmaceutical; Cyclopropanes; Dideoxynucleosides; Drug Approval; Furans; HIV Protease Inhibitors; Humans; Organophosphonates; Oxazines; Reverse Transcriptase Inhibitors; Sulfonamides	1999
Clinical history of efavirenz. International journal of clinical practice. Supplement, 1999, Volume: 103 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Clinical Trials as Topic; Cyclopropanes; Drug Interactions; Humans; Oxazines; Reverse Transcriptase Inhibitors	1999
Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives. Current pharmaceutical design, 2002, Volume: 8, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzodiazepinones; Benzoxazines; Cyclopropanes; Delavirdine; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Viral; Drug Therapy, Combination; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Structure; Nevirapine; Nucleosides; Oxazines; Reverse Transcriptase Inhibitors; Spiro Compounds; Thymidine; Uridine	2002

Trials

31 trial(s) available for efavirenz and Acquired Immune Deficiency Syndrome

Article	Year
[Effectiveness and safety of generic version of lamivudine/tenofovir and efavirenz in treatment naïve HIV-infected patients: a nonrandomized, open-label, phase IV study in Cali-Colombia, 2012-2014]. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2019, Volume: 36, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Analysis of Variance; Anti-HIV Agents; Benzoxazines; Colombia; Cyclopropanes; Drugs, Generic; Female; Humans; Lamivudine; Male; Prospective Studies; Reproducibility of Results; Statistics, Nonparametric; Tenofovir; Time Factors; Treatment Outcome; Young Adult	2019
Differential subcutaneous adipose tissue gene expression patterns in a randomized clinical trial of efavirenz or lopinavir-ritonavir in antiretroviral-naive patients. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adipogenesis; Adiponectin; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Body Composition; CCAAT-Enhancer-Binding Proteins; Cyclopropanes; Deoxycytidine; Drug Combinations; Emtricitabine; Energy Metabolism; Female; Gene Expression; Glucose; Glucose Transporter Type 4; HIV-1; Humans; Inflammation; Lipid Metabolism; Lipoprotein Lipase; Lopinavir; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Ritonavir; Subcutaneous Fat; Tenofovir	2014
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. Pharmacogenetics and genomics, 2015, Volume: 25, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Creatinine; Cyclopropanes; Dideoxynucleosides; Female; Genome-Wide Association Study; Humans; Male; Polymorphism, Single Nucleotide; Ritonavir; Tenofovir	2015
A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy. The Journal of infectious diseases, 2008, Jul-15, Volume: 198, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Diarrhea; Drug Therapy, Combination; Glucose Tolerance Test; HIV Protease Inhibitors; Humans; Lopinavir; Nausea; Pyrimidinones; Ritonavir; RNA, Viral; Time Factors; Treatment Outcome; Viral Load	2008
Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution. HIV medicine, 2009, Volume: 10, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Body Fat Distribution; Cardiovascular Diseases; Coronary Disease; Cyclopropanes; Drug Therapy, Combination; Epidemiologic Methods; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Immune Reconstitution Inflammatory Syndrome; Male; Metabolic Syndrome; Middle Aged; Treatment Outcome	2009
Substitution of nevirapine because of efavirenz toxicity in AIDS clinical trials group A5095. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Mar-01, Volume: 50, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Antiviral Agents; Benzoxazines; Cyclopropanes; Female; Humans; Liver; Male; Middle Aged; Nevirapine; Withholding Treatment	2010
Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C. The Pediatric infectious disease journal, 2010, Volume: 29, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Congenital Abnormalities; Cyclopropanes; Female; Humans; Infant; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Young Adult; Zidovudine	2010
A randomized factorial trial comparing 4 treatment regimens in treatment-naive HIV-infected persons with AIDS and/or a CD4 cell count <200 cells/μL in South Africa. The Journal of infectious diseases, 2010, Nov-15, Volume: 202, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Didanosine; Drug Therapy, Combination; Female; HIV; Humans; Lamivudine; Lopinavir; Male; Pyrimidinones; Ritonavir; RNA, Viral; South Africa; Stavudine; Treatment Outcome; Zidovudine	2010
Open-label randomized multicenter selection study of once daily antiretroviral treatment regimen comparing ritonavir-boosted atazanavir to efavirenz with fixed-dose abacavir and lamivudine. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Adult; Alanine Transaminase; Alkynes; Anti-Retroviral Agents; Atazanavir Sulfate; Benzoxazines; Bilirubin; Cholesterol; Cyclopropanes; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; Humans; Japan; Lamivudine; Oligopeptides; Pyridines; Ritonavir; Treatment Outcome	2011
HIV/AIDS patients display lower relative bioavailability of efavirenz than healthy subjects. Clinical pharmacokinetics, 2011, Volume: 50, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Biological Availability; Body Weight; Cyclopropanes; Female; Half-Life; HIV Infections; Humans; Male; Middle Aged; Models, Biological; Nonlinear Dynamics; Pharmacogenetics; Sex Factors; Tissue Distribution; Uganda; Young Adult	2011
Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial. Lancet (London, England), 2011, Jul-16, Volume: 378, Issue:9787 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Double-Blind Method; Drug Administration Schedule; Emtricitabine; Female; HIV Reverse Transcriptase; HIV-1; Humans; Male; Middle Aged; Mutation; Nitriles; Nucleosides; Nucleotides; Organophosphonates; Pyrimidines; Reverse Transcriptase Inhibitors; Rilpivirine; Tenofovir; Treatment Outcome; Viral Load	2011
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial. Lancet (London, England), 2011, Jul-16, Volume: 378, Issue:9787 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Double-Blind Method; Drug Administration Schedule; Emtricitabine; Female; HIV Reverse Transcriptase; HIV-1; Humans; Male; Middle Aged; Mutation; Nitriles; Organophosphonates; Pyrimidines; Reverse Transcriptase Inhibitors; Rilpivirine; Tenofovir; Treatment Outcome; Viral Load	2011
Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384. Journal of acquired immune deficiency syndromes (1999), 2011, Dec-01, Volume: 58, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Base Sequence; Benzoxazines; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cyclopropanes; Drug Therapy, Combination; Female; Genome, Mitochondrial; Haplotypes; Humans; Male; Middle Aged; Molecular Sequence Data; Nelfinavir; Polymorphism, Single Nucleotide; RNA, Viral; Treatment Outcome; Viral Load; Young Adult	2011
Effect modification by sex and baseline CD4+ cell count among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial. AIDS research and human retroviruses, 2012, Volume: 28, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; Botswana; CD4 Lymphocyte Count; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Likelihood Functions; Male; Middle Aged; Nevirapine; Retrospective Studies; Sex Distribution; Time Factors; Treatment Outcome; Viral Load; Young Adult	2012
Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE. HIV medicine, 2012, Volume: 13, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Black or African American; CD4 Lymphocyte Count; Cyclopropanes; Dideoxynucleosides; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Nitriles; Organophosphonates; Pyrimidines; Rilpivirine; Sex Factors; Tenofovir; Treatment Outcome; Viral Load; Zidovudine	2012
Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir. AIDS (London, England), 2012, Jul-17, Volume: 26, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Biomarkers; C-Reactive Protein; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Combinations; Emtricitabine; Female; HIV-1; Humans; Inflammation; Interleukin-6; Lamivudine; Male; Oligopeptides; Organophosphonates; Pyridines; Ritonavir; Tenofovir; Tumor Necrosis Factor-alpha	2012
High effectiveness of efavirenz-based highly active antiretroviral therapy in HIV-1-infected patients with fewer than 100 CD4 cells/microl and opportunistic diseases: the EfaVIP Study (Efavirenz in Very Immunosuppressed Patients). AIDS (London, England), 2002, Jul-26, Volume: 16, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Female; HIV-1; Humans; Immunocompromised Host; Male; Middle Aged; Oxazines; Recurrence; Retrospective Studies	2002
Pharmacokinetic and pharmacodynamic investigation of efavirenz in the semen and blood of human immunodeficiency virus type 1-infected men. The Journal of infectious diseases, 2002, Nov-01, Volume: 186, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; HIV Infections; HIV-1; Humans; Male; Metabolic Clearance Rate; Oxazines; Semen	2002
Population pharmacokinetics and pharmacodynamics of efavirenz, nelfinavir, and indinavir: Adult AIDS Clinical Trial Group Study 398. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Bayes Theorem; Benzoxazines; Cyclopropanes; Drug Interactions; Female; HIV Protease Inhibitors; Humans; Indinavir; Male; Models, Biological; Nelfinavir; Oxazines; Population Surveillance; Treatment Failure	2003
Efavirenz-based regimen as treatment of advanced AIDS with cryptococcal meningitis. Journal of acquired immune deficiency syndromes (1999), 2003, May-01, Volume: 33, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cryptococcus neoformans; Cyclopropanes; Female; HIV; Humans; Male; Meningitis, Cryptococcal; Oxazines; RNA, Viral; Thailand; Time Factors	2003
Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years. Journal of virology, 2003, Volume: 77, Issue:20 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; DNA, Viral; HIV-1; Humans; Indinavir; Longitudinal Studies; Oxazines; RNA, Viral; Time Factors; Viremia	2003
A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir. Antiviral therapy, 2003, Volume: 8, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Alkynes; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; HIV-1; Humans; Indinavir; Male; Nelfinavir; Organophosphonates; Oxazines; Phenotype; Reverse Transcriptase Inhibitors; Treatment Failure	2003
Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study. AIDS (London, England), 2004, Dec-03, Volume: 18, Issue:18 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Central Nervous System Diseases; Cohort Studies; Cyclopropanes; Cytochrome P-450 Enzyme System; Double-Blind Method; Female; Humans; Male; Oxazines; Pharmacogenetics; Polymorphism, Genetic	2004
Increased dose of lopinavir/ritonavir compensates for efavirenz-induced drug-drug interaction in HIV-1-infected children. Journal of acquired immune deficiency syndromes (1999), 2005, May-01, Volume: 39, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Alkynes; Anti-HIV Agents; Area Under Curve; Benzoxazines; Child; Child, Preschool; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Female; HIV Protease Inhibitors; Humans; Lopinavir; Male; Oxazines; Pyrimidinones; Ritonavir; Safety	2005
Pharmacokinetics and pharmacodynamics of low dose mycophenolate mofetil in HIV-infected patients treated with abacavir, efavirenz and nelfinavir. Clinical pharmacokinetics, 2005, Volume: 44, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cell Line; Cell Proliferation; Cyclopropanes; Dideoxynucleosides; Female; HIV-1; Humans; IMP Dehydrogenase; Male; Mycophenolic Acid; Nelfinavir; Oxazines; Viral Load	2005
Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study. Pharmacogenetics and genomics, 2006, Volume: 16, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Benzoxazines; Clinical Trials as Topic; Cyclopropanes; Genetic Predisposition to Disease; Humans; Models, Genetic; Oxazines; Treatment Failure; Treatment Outcome	2006
Efficacy and tolerability of long-term efavirenz plus nucleoside reverse transcriptase inhibitors for HIV-1 infection. AIDS (London, England), 2008, Jan-11, Volume: 22, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Aged, 80 and over; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Administration Schedule; Europe; Female; HIV-1; Humans; Male; Middle Aged; North America; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load	2008
Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy. The Journal of infectious diseases, 1999, Volume: 180, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Oxazines; Viral Load; Zidovudine	1999
Update on study 006--EFV + AZT + 3TC versus the current 'standard of care' IDV + AZT + 3TC. International journal of clinical practice. Supplement, 1999, Volume: 103 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Humans; Indinavir; Lamivudine; Lipid Metabolism; Oxazines; Viral Load; Zidovudine	1999
Efavirenz combination potent after 48 weeks. AIDS patient care and STDs, 1998, Volume: 12, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Humans; Indinavir; Organic Chemicals; Oxazines; Treatment Outcome	1998
Sustiva combination effective as initial treatment. AIDS patient care and STDs, 1998, Volume: 12, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Indinavir; Lamivudine; Oxazines; Treatment Outcome	1998

Other Studies

81 other study(ies) available for efavirenz and Acquired Immune Deficiency Syndrome

Article	Year
Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains. Bioorganic & medicinal chemistry letters, 2007, Apr-01, Volume: 17, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cell Line; Chemistry, Pharmaceutical; Cyclopropanes; Drug Design; Enzyme Inhibitors; HIV-1; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Conformation; Mutation; Nevirapine; Reverse Transcriptase Inhibitors	2007
Influence of the cytochrome P450 2B6 genotype on population pharmacokinetics of efavirenz in human immunodeficiency virus patients. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; Alkynes; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Chromatography, High Pressure Liquid; Cyclopropanes; Cytochrome P-450 CYP2B6; Female; Genotype; HIV Infections; Humans; Male; Middle Aged; Oxidoreductases, N-Demethylating; Polymorphism, Genetic; Sex Factors	2009
Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate. Bioorganic & medicinal chemistry letters, 2009, Oct-15, Volume: 19, Issue:20 Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Cell Line; Drug Resistance, Viral; HIV Reverse Transcriptase; Humans; Microsomes, Liver; Nitriles; Pyrazoles; Rats; Reverse Transcriptase Inhibitors	2009
Optimizing Treatment for Human Immunodeficiency Virus to Improve Clinical Outcomes Using Precision Medicine. American journal of epidemiology, 2023, 08-04, Volume: 192, Issue:8 Topics: Acquired Immunodeficiency Syndrome; HIV; HIV Infections; Humans; Precision Medicine; Reverse Transcriptase Inhibitors	2023
Evaluation of Glomerular Filtration Rate Trends in People Living With HIV Corrected by the Baseline Glomerular Filtration Rate. Journal of acquired immune deficiency syndromes (1999), 2023, 09-01, Volume: 94, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Glomerular Filtration Rate; HIV Infections; Humans; Hypertension; Renal Insufficiency	2023
Associations of modern initial antiretroviral therapy regimens with all-cause mortality in people living with HIV in resource-limited settings: a retrospective multicenter cohort study in China. Nature communications, 2023, 09-02, Volume: 14, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Benzoxazines; China; Cohort Studies; Humans; Lopinavir; Nevirapine; Retrospective Studies	2023
Efavirenz-loaded intranasal microemulsion for crossing blood-CNS interfaces in neuronal-AIDS: pharmacokinetic and Pharmaceutical development and technology, 2020, Volume: 25, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Administration, Intranasal; Alkynes; Animals; Benzoxazines; Blood-Brain Barrier; Central Nervous System; Cyclopropanes; Drug Delivery Systems; Emulsions; Male; Nasal Mucosa; Neurons; Rats; Rats, Wistar; Tissue Distribution	2020
Traditional Chinese Medicine Can Improve the Immune Reconstruction of HIV/AIDS Patients. AIDS research and human retroviruses, 2020, Volume: 36, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Drugs, Chinese Herbal; HIV Infections; Humans; Immune Reconstitution; Lamivudine; Medicine, Chinese Traditional; Middle Aged; Pilot Projects; Prospective Studies; T-Lymphocytes; Tenofovir; Treatment Outcome; Young Adult	2020
Development of Pediatric Orodispersible Tablets Based on Efavirenz as a New Therapeutic Alternative. Current HIV research, 2020, Volume: 18, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Alkynes; Benzoxazines; beta-Cyclodextrins; Calorimetry, Differential Scanning; Cyclopropanes; Drug Compounding; Hardness; Humans; Pediatrics; Reverse Transcriptase Inhibitors; Solubility; Tablets	2020
Incident AIDS or Death After Initiation of Human Immunodeficiency Virus Treatment Regimens Including Raltegravir or Efavirenz Among Adults in the United States. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Jun-01, Volume: 64, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Cyclopropanes; Female; HIV Infections; HIV Integrase Inhibitors; HIV-1; Humans; Male; Middle Aged; Raltegravir Potassium; Reverse Transcriptase Inhibitors; RNA, Viral; Tenofovir; United States; Viral Load; Young Adult	2017
Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological Conditions. Journal of acquired immune deficiency syndromes (1999), 2018, 01-01, Volume: 77, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Alkynes; Americas; Atazanavir Sulfate; Benzoxazines; Cohort Studies; Cyclopropanes; Darunavir; Europe; Female; HIV Protease Inhibitors; Humans; Leukoencephalopathy, Progressive Multifocal; Lopinavir; Male; Meningitis, Cryptococcal; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Toxoplasmosis	2018
High predictive value of CYP2B6 SNPs for steady-state plasma efavirenz levels in South African HIV/AIDS patients. Pharmacogenetics and genomics, 2013, Volume: 23, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Benzoxazines; Black People; Case-Control Studies; Constitutive Androstane Receptor; Cyclopropanes; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Gene Frequency; Haplotypes; HIV Infections; Humans; Multivariate Analysis; Pharmacogenetics; Polymorphism, Single Nucleotide; South Africa; White People	2013
A rapid and selective HPLC-UV method for the quantitation of efavirenz in plasma from patients on concurrent HIV/AIDS and tuberculosis treatments. Biomedical chromatography : BMC, 2013, Volume: 27, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Benzoxazines; Chromatography, High Pressure Liquid; Cyclopropanes; Drug Monitoring; Female; Humans; Limit of Detection; Male; Reverse Transcriptase Inhibitors; Time Factors; Tuberculosis	2013
Hepatitis B prevalence and influence on HIV treatment outcome and mortality in the Chilean AIDS Cohort. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2013, Volume: 17, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Chile; Coinfection; Cyclopropanes; Female; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Middle Aged; Prevalence; Proportional Hazards Models; Retrospective Studies; Treatment Outcome	2013
Challenges of antiretroviral treatment monitoring in rural and remote-access regions in Africa. AIDS research and human retroviruses, 2014, Volume: 30, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Adult; Africa; Alkynes; Anti-HIV Agents; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Drug Monitoring; Drug Resistance, Viral; Female; HIV-1; Hospitals, Rural; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Rural Health Services; Rural Population; Stavudine; Treatment Outcome; Zidovudine	2014
MicroRNA-150 is a potential biomarker of HIV/AIDS disease progression and therapy. PloS one, 2014, Volume: 9, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Biomarkers; CD4 Lymphocyte Count; Cyclopropanes; Disease Progression; Drug Resistance, Viral; Female; Gene Expression Regulation; HIV; Humans; Lamivudine; Leukocytes, Mononuclear; Male; MicroRNAs; Nevirapine; Stavudine; Treatment Outcome; Viral Load; Zidovudine	2014
A simple, rapid, economical, and practical method for the determination of efavirenz in plasma of Chinese AIDS patients by reverse phase high-performance liquid chromatography with ultraviolet detector. Bioscience trends, 2014, Volume: 8, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; China; Chromatography, High Pressure Liquid; Cyclopropanes; Drug Monitoring; Drug Stability; Female; Humans; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Specimen Handling; Young Adult	2014
[Analysis on HIV suppression effect after initiating antiretroviral treatment and related factors among AIDS patients in Henan province during 2008 and 2013]. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine], 2015, Volume: 49, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Female; Health Facilities; HIV Infections; Humans; Lamivudine; Male; Nevirapine; Stavudine; Time-to-Treatment; Treatment Outcome; Zidovudine	2015
CYP2B66, CYP2B618, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe. BMC pharmacology & toxicology, 2015, Mar-27, Volume: 16 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Alleles; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B; Benzoxazines; Body Weight; Case-Control Studies; Cyclopropanes; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Drug Interactions; Female; Hallucinations; Headache; Humans; Male; Models, Biological; Rifampin; Sex Characteristics; Sleep Wake Disorders; Tuberculosis; Zimbabwe	2015
Targeting of AIDS related encephalopathy using phenylalanine anchored lipidic nanocarrier. Colloids and surfaces. B, Biointerfaces, 2015, Jul-01, Volume: 131 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Animals; Benzoxazines; Blood-Brain Barrier; Brain Diseases; Cells, Cultured; Cyclopropanes; Drug Carriers; Female; Humans; Lipids; Male; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Nanoparticles; Phenylalanine; Rats, Wistar; Reverse Transcriptase Inhibitors; Tissue Distribution	2015
Efavirenz Plasma Concentrations and HIV Viral Load in HIV/AIDS-tuberculosis Infection Patients Treated with Rifampicin. Acta medica Indonesiana, 2016, Volume: 48, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Antibiotics, Antitubercular; Benzoxazines; CD4 Lymphocyte Count; Central Nervous System; Cyclopropanes; Female; Humans; Male; Middle Aged; Rifampin; Tuberculosis; Viral Load; Young Adult	2016
Short communication: oral lesions in HIV/AIDS patients undergoing HAART including efavirenz. AIDS research and human retroviruses, 2008, Volume: 24, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Female; HIV Protease Inhibitors; HIV-1; Humans; Male; Middle Aged; Mouth Diseases; Prevalence; Ritonavir; Saquinavir; Viral Load	2008
Therapeutic monitoring is necessary for the association itraconazole and efavirenz in a patient with AIDS and disseminated histoplasmosis. AIDS (London, England), 2008, Sep-12, Volume: 22, Issue:14 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Antifungal Agents; Benzoxazines; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Female; Histoplasma; Histoplasmosis; Humans; Itraconazole; Metabolic Clearance Rate; Middle Aged	2008
Clinical manifestations and antiretroviral management of HIV/AIDS patients with tuberculosis co-infection in Kramat 128 Hospital. Acta medica Indonesiana, 2008, Volume: 40, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Female; HIV Infections; Humans; Indonesia; Male; Middle Aged; Nevirapine; Outpatient Clinics, Hospital; Outpatients; Risk Factors; Treatment Outcome; Tuberculosis, Pulmonary	2008
Long-term efficacy and safety of TDM-assisted combination of voriconazole plus efavirenz in an AIDS patient with cryptococcosis and liver cirrhosis. The Annals of pharmacotherapy, 2009, Volume: 43, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Benzoxazines; Cyclopropanes; Drug Monitoring; Drug Therapy, Combination; Humans; Liver Cirrhosis; Male; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole	2009
Pharmacokinetics of plasma efavirenz and CYP2B6 polymorphism in southern Chinese. Therapeutic drug monitoring, 2009, Volume: 31, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Alkynes; Anti-HIV Agents; Aryl Hydrocarbon Hydroxylases; Benzoxazines; China; Cyclopropanes; Cytochrome P-450 CYP2B6; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Leukocytes, Mononuclear; Male; Oxidoreductases, N-Demethylating; Polymorphism, Genetic; Prescriptions	2009
[Tolerance study of a triple first-line antiretroviral combination zidovudine, lamivudine and efavirenz in Dakar, Senegal]. Bulletin de la Societe de pathologie exotique (1990), 2009, Volume: 102, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anemia; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Drug Tolerance; HIV-1; Humans; Lamivudine; Senegal; Zidovudine	2009
[Acute renal failure and hypercalcemia in an AIDS patient on tenofovir and low-dose vitamin D therapy with immune reconstitution inflammatory syndrome]. Medizinische Klinik (Munich, Germany : 1983), 2009, Oct-15, Volume: 104, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adenine; Adrenal Cortex Hormones; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Calcium; Cholecalciferol; Cyclopropanes; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; Female; Humans; Hypercalcemia; Immune Reconstitution Inflammatory Syndrome; Kidney Function Tests; Mycobacterium avium-intracellulare Infection; Organophosphonates; Osteoporosis; Tenofovir	2009
Decreased plasma efavirenz concentrations in a patient receiving rifabutin. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010, Oct-01, Volume: 67, Issue:19 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Antibiotics, Antitubercular; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Interactions; Humans; Male; Meningitis, Aseptic; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Viral Load	2010
Synergistic encapsulation of the anti-HIV agent efavirenz within mixed poloxamine/poloxamer polymeric micelles. Nanomedicine : nanotechnology, biology, and medicine, 2011, Volume: 7, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Delivery Systems; Drug Synergism; Ethylenediamines; HIV; Humans; Micelles; Nanocapsules; Poloxamer; Solubility	2011
AIDS diarrhea and antiretroviral drug concentrations: a matched-pair cohort study in Port au Prince, Haiti. The American journal of tropical medicine and hygiene, 2011, Volume: 84, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Diarrhea; Female; Haiti; HIV Infections; HIV-1; Humans; Male; Matched-Pair Analysis; Prospective Studies; RNA, Viral; Viral Load	2011
HIV/AIDS and the road to Rome. Lancet (London, England), 2011, Jul-16, Volume: 378, Issue:9787 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Clinical Trials, Phase III as Topic; Congresses as Topic; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; HIV Seropositivity; Humans; Malawi; Male; Nitriles; Pregnancy; Pregnancy Complications, Infectious; Primary Prevention; Public Health; Pyrimidines; Randomized Controlled Trials as Topic; Rilpivirine; Sexual Behavior; Sexual Partners; South Africa; Stereotyping; Treatment Outcome	2011
Battles with donors cloud Malawi's HIV prevention plan. Lancet (London, England), 2011, Jul-16, Volume: 378, Issue:9787 Topics: Acquired Immunodeficiency Syndrome; Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Charities; Cyclopropanes; Drug Costs; Drug Therapy, Combination; Female; Health Policy; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; International Cooperation; Lamivudine; Malawi; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir	2011
No increased risk of hepatotoxicity in long-term use of nonnucleoside reverse transcriptase inhibitors in HIV-infected patients. HIV medicine, 2012, Volume: 13, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; CD4-Positive T-Lymphocytes; Chemical and Drug Induced Liver Injury; Child; Coinfection; Cyclopropanes; Female; Hepatitis C; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Young Adult	2012
Monitoring of HAART regime antiretrovirals in serum of acquired immunodeficiency syndrome patients by micellar liquid chromatography. The Analyst, 2012, Sep-21, Volume: 137, Issue:18 Topics: Acquired Immunodeficiency Syndrome; Adenine; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Chromatography, Liquid; Cyclopropanes; Drug Monitoring; Humans; Lamivudine; Organophosphonates; Stavudine; Tenofovir; Zidovudine	2012
Underlying genetic structure impacts the association between CYP2B6 polymorphisms and response to efavirenz and nevirapine. AIDS (London, England), 2012, Oct-23, Volume: 26, Issue:16 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2B6; Female; Genetic Variation; Genotype; Humans; Nevirapine; Oxidoreductases, N-Demethylating; Polymorphism, Single Nucleotide; United States; Viral Load	2012
Penicillium marneffei chylous ascites in acquired immune deficiency syndrome: a case report. World journal of gastroenterology, 2012, Oct-07, Volume: 18, Issue:37 Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Alkynes; Amphotericin B; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Chylous Ascites; Cyclopropanes; Diagnosis, Differential; Humans; Male; Middle Aged; Mycoses; Penicillium; Pyrimidines; Sepsis; Triazoles; Voriconazole	2012
PXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients. BMC medical genetics, 2012, Nov-22, Volume: 13 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Benzoxazines; Black People; Constitutive Androstane Receptor; Cyclopropanes; Gene Frequency; Haplotypes; HIV Infections; Humans; Middle Aged; Polymorphism, Single Nucleotide; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid	2012
Cost-effectiveness of efavirenz vs rilpivirine in HIV patients initiating first-line combination antiretroviral therapy. Journal of medical economics, 2013, Volume: 16, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cost-Benefit Analysis; Cyclopropanes; Drug Therapy, Combination; HIV Infections; Humans; Life Expectancy; Markov Chains; Models, Economic; Nitriles; Pyrimidines; Reproducibility of Results; Reverse Transcriptase Inhibitors; Rilpivirine	2013
When will once (-a day) be enough? The Hopkins HIV report : a bimonthly newsletter for healthcare providers, 2000, Volume: 12, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Deoxycytidine; Didanosine; Emtricitabine; Humans; Hydroxyurea; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Zidovudine	2000
Anti-HIV agents. Efavirenz makes its mark in AIDS. TreatmentUpdate, 2002, Volume: 14, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Humans; Oxazines; Survival	2002
Fulminant hepatic failure after the start of an efavirenz-based HAART regimen in a treatment-naive female AIDS patient without hepatitis virus co-infection. The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Female; Hepatitis, Viral, Human; HIV-1; Humans; Liver Failure; Oxazines	2002
Efavirenz helps get rid of Kaposi's sarcoma (KS). TreatmentUpdate, 2002, Volume: 14, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Humans; Male; Oxazines; Reverse Transcriptase Inhibitors; Sarcoma, Kaposi; Viral Load	2002
AIDS drug in halted trial less effective as monotherapy. The AIDS reader, 2003, Volume: 13, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Clinical Trials as Topic; Cyclopropanes; Dideoxynucleosides; Drug Combinations; Drug Therapy, Combination; Humans; Lamivudine; Oxazines; Viral Load; Zidovudine	2003
Pharmacokinetics of indinavir/ritonavir (800/100 mg) in combination with efavirenz (600 mg) in HIV-1-infected subjects. Journal of acquired immune deficiency syndromes (1999), 2003, Oct-01, Volume: 34, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Female; HIV-1; Humans; Indinavir; Male; Oxazines; Ritonavir	2003
[Ensuring high adherence. Clever combination assures therapeutic success]. MMW Fortschritte der Medizin, 2003, Apr-28, Volume: 145 Spec No 1 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Combinations; Humans; Lamivudine; Oxazines; Patient Compliance; Randomized Controlled Trials as Topic; Treatment Outcome; Zidovudine	2003
[Psychiatric diseases and HIV infection. These patients are dually stigmatized]. MMW Fortschritte der Medizin, 2003, Apr-28, Volume: 145 Spec No 1 Topics: Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Diagnosis, Differential; Humans; Oxazines; Patient Compliance; Prejudice; Psychoses, Substance-Induced; Psychotic Disorders	2003
[Nevirapine has gained acceptance. Good antiretroviral effect--favorable lipid profile]. MMW Fortschritte der Medizin, 2003, Apr-28, Volume: 145 Spec No 1 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Nevirapine; Oxazines; Randomized Controlled Trials as Topic	2003
[CROI highlights of D:A:D Study (Data Collection on Adverse Events of Anti-HIV Drugs Study) and 2NN Study. Stepping into the grease pot]. MMW Fortschritte der Medizin, 2003, Apr-28, Volume: 145 Spec No 1 Topics: Acquired Immunodeficiency Syndrome; Adverse Drug Reaction Reporting Systems; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Data Collection; Humans; Lipids; Myocardial Infarction; Nevirapine; Oxazines; Treatment Outcome	2003
["Once daily" drugs simplify therapy. Rp. HAART once daily]. MMW Fortschritte der Medizin, 2003, Apr-28, Volume: 145 Spec No 1 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Drug Administration Schedule; Humans; Oligopeptides; Oxazines; Patient Compliance; Pyridines; Treatment Outcome	2003
Merck broke AIDS drug price promise, says MSF. Lancet (London, England), 2004, Mar-13, Volume: 363, Issue:9412 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Developing Countries; Drug and Narcotic Control; Drug Costs; Drug Industry; Humans; Oxazines; Prevalence	2004
Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence. Journal of acquired immune deficiency syndromes (1999), 2005, Apr-15, Volume: 38, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Central Nervous System Diseases; Cognition Disorders; Cyclopropanes; Employment; Female; Humans; Male; Mood Disorders; Oxazines; Patient Compliance; Quality of Life; Retrospective Studies; Risk-Taking; Surveys and Questionnaires	2005
Myelomeningocele in an infant with intrauterine exposure to efavirenz. Journal of perinatology : official journal of the California Perinatal Association, 2005, Volume: 25, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Arnold-Chiari Malformation; Benzoxazines; Cyclopropanes; Female; Humans; Infant, Newborn; Male; Meningomyelocele; Oxazines; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second	2005
Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz. Pharmacogenetics and genomics, 2005, Volume: 15, Issue:12 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Animals; Anti-HIV Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Benzoxazines; Black People; Chlorocebus aethiops; COS Cells; Cyclopropanes; Cytochrome P-450 CYP2B6; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Humans; Oxazines; Oxidoreductases, N-Demethylating; Polymorphism, Genetic	2005
Economic impact of antiretroviral therapy prescription decisions in the context of rapid scaling-up of access to treatment: lessons from Mexico. AIDS (London, England), 2006, Jan-02, Volume: 20, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Didanosine; Drug Prescriptions; Health Care Costs; Health Services Accessibility; HIV Infections; HIV Protease Inhibitors; Humans; Mexico; Oxazines; Patient Compliance; Practice Guidelines as Topic; Saquinavir; Zidovudine	2006
Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Feb-01, Volume: 42, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Benzoxazines; Black or African American; Cyclopropanes; Cytochrome P-450 CYP2B6; Female; Genotype; Half-Life; Hispanic or Latino; Humans; Male; Native Hawaiian or Other Pacific Islander; Oxazines; Oxidoreductases, N-Demethylating; Polymorphism, Genetic; Viral Load; White People	2006
HIV protease inhibitor therapy reverses neutrophil apoptosis in AIDS patients by direct calpain inhibition. Apoptosis : an international journal on programmed cell death, 2006, Volume: 11, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Apoptosis; Benzoxazines; Calpain; Case-Control Studies; Caspase 3; Caspases; Cells, Cultured; Cyclopropanes; Female; HIV Protease Inhibitors; Humans; Indinavir; Kinetics; Leukocytes, Mononuclear; Male; Neutrophils; Oxazines; Proteasome Endopeptidase Complex; Zidovudine	2006
A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loads. The Journal of infectious diseases, 2006, Jul-01, Volume: 194, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Alkynes; Benzoxazines; Cohort Studies; Cyclopropanes; Dideoxynucleosides; Drug Therapy, Combination; Female; History, 21st Century; Humans; Lipids; Male; Middle Aged; Oxazines; Prospective Studies; Reverse Transcriptase Inhibitors; Time Factors; Viral Load	2006
Effects on growth after switching protease inhibitors to efavirenz in HIV-1-infected children. International journal of antimicrobial agents, 2007, Volume: 29, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Alkynes; Anti-HIV Agents; Benzoxazines; Child; Cyclopropanes; Female; Growth; HIV Protease Inhibitors; HIV-1; Humans; Male; Oxazines	2007
Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda. Journal of acquired immune deficiency syndromes (1999), 2007, Apr-01, Volume: 44, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Cyclopropanes; Exanthema; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Nevirapine; Pancreatitis; Peripheral Nervous System Diseases; Proportional Hazards Models; Rural Health; Stavudine; Survival Analysis; Uganda	2007
Methodological standards in non-inferiority AIDS trials: moving from adherence to compliance: response. BMC medical research methodology, 2007, Mar-02, Volume: 7 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Clinical Trials as Topic; Cyclopropanes; Humans; Nevirapine; Oxazines; Patient Compliance; Research Design	2007
CYP2B6 983T>C polymorphism is prevalent in West Africa but absent in Papua New Guinea: implications for HIV/AIDS treatment. British journal of clinical pharmacology, 2007, Volume: 64, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Alleles; Anti-HIV Agents; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Black or African American; Cyclopropanes; Cytochrome P-450 CYP2B6; Genotype; Haplotypes; HIV Infections; Humans; Oxidoreductases, N-Demethylating; Papua New Guinea; Polymorphism, Single Nucleotide; Population Groups; United States	2007
Drug-drug interaction between itraconazole and efavirenz in a patient with AIDS and disseminated histoplasmosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Sep-15, Volume: 45, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Antifungal Agents; Antigens, Fungal; Benzoxazines; Cyclopropanes; Drug Interactions; Histoplasma; Histoplasmosis; Humans; Itraconazole; Male	2007
Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosine. The Journal of infectious diseases, 2007, Dec-01, Volume: 196, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Didanosine; Female; Genotype; HIV Reverse Transcriptase; HIV-1; Humans; Lopinavir; Male; Middle Aged; Mutation; Nelfinavir; Nevirapine; Pyrimidinones; Reverse Transcriptase Inhibitors; RNA, Viral; Salvage Therapy	2007
High prevalence of the CYP2B6 516G-->T(6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe. European journal of clinical pharmacology, 2008, Volume: 64, Issue:4* Topics: Acquired Immunodeficiency Syndrome; Adult; Algorithms; Alkynes; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2B6; Female; Gene Frequency; Genetic Variation; Genotype; HIV Infections; Humans; Male; Models, Statistical; Oxidoreductases, N-Demethylating; Population; Reverse Transcriptase Inhibitors; Sex Factors; Zimbabwe	2008
[HIV-1 genotypic resistance profiles in children failing highly active antiretroviral therapy]. Zhonghua yi xue za zhi, 2007, Dec-11, Volume: 87, Issue:46 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Child; Child, Preschool; China; Cyclopropanes; Delavirdine; Drug Resistance, Viral; Genotype; HIV-1; Humans; Mutation; Nevirapine; Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Viral Load; Zidovudine	2007
Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda. Journal of acquired immune deficiency syndromes (1999), 2008, Mar-01, Volume: 47, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cardiovascular Diseases; CD4 Lymphocyte Count; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyclopropanes; Female; Home Care Services; Humans; Lipids; Male; Middle Aged; Nevirapine; Risk Factors; Rural Health; Time Factors; Triglycerides; Uganda	2008
Treatment for AIDS. The Journal of the American Osteopathic Association, 1998, Volume: 98, Issue:10 Topics: Abnormalities, Drug-Induced; Acquired Immunodeficiency Syndrome; Adult; Alkynes; Benzoxazines; Child; Child, Preschool; Clinical Trials as Topic; Cyclopropanes; Drug Approval; Female; HIV Infections; Humans; Infant, Newborn; Male; Oxazines; Pregnancy; Reverse Transcriptase Inhibitors; United States	1998
Hope for HIV patients. News from the 12th International Conference on HIV and AIDS. Canadian family physician Medecin de famille canadien, 1999, Volume: 45 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Antigens; Cyclopropanes; Diet Therapy; HIV Infections; Humans; Hyperlipidemias; Oxazines	1999
[Lipodystrophy and antiretroviral agents]. Revista clinica espanola, 1999, Volume: 199, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; HIV Protease Inhibitors; HIV-1; Humans; Hyperlipidemias; Lipodystrophy; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Syndrome	1999
[Antiretroviral therapy. NNRTI (non-nucleoside reverse transcriptase inhibitor)]. MMW Fortschritte der Medizin, 2000, Mar-13, Volume: 142 Suppl 1 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cohort Studies; Cyclopropanes; Drug Therapy, Combination; Humans; Oxazines; Reverse Transcriptase Inhibitors; Treatment Outcome	2000
[Protease inhibitor saving alternatives]. MMW Fortschritte der Medizin, 2000, Mar-13, Volume: 142 Suppl 1 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Clinical Trials as Topic; Cyclopropanes; Drug Therapy, Combination; Humans; Oxazines; Reverse Transcriptase Inhibitors	2000
Switching from a PI-based to a PI-sparing regimen for management of metabolic or clinical fat redistribution. The AIDS reader, 2000, Volume: 10, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Adipose Tissue; Alkynes; Benzoxazines; Cyclopropanes; Dideoxynucleosides; HIV Protease Inhibitors; Humans; Lipodystrophy; Nevirapine; Oxazines	2000
Economic analysis of initial HIV treatment. Efavirenz- versus indinavir-containing triple therapy. PharmacoEconomics, 2001, Volume: 19, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Disease Progression; Drug Costs; Drug Therapy, Combination; Health Care Costs; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Models, Economic; Oxazines; Reverse Transcriptase Inhibitors	2001
[Fatal lactic acidosis in a patient with acquired immunodeficiency syndrome treated with highly active antiretroviral therapy. Report of a case]. Revista medica de Chile, 2000, Volume: 128, Issue:10 Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Didanosine; Fatal Outcome; Female; Humans; Oxazines; Severity of Illness Index; Stavudine	2000
Efavirenz (SUSTIVA) expanded access begins October 1. AIDS treatment news, 1997, Sep-19, Issue:No 279 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Therapy, Combination; Humans; Oxazines; Reverse Transcriptase Inhibitors	1997
DMP-266 and adefovir dipivoxil: 2 new AIDS drugs available to patients without treatment options. BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1997 Topics: Acquired Immunodeficiency Syndrome; Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Clinical Trials as Topic; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Humans; Oxazines; Patient Selection; Reverse Transcriptase Inhibitors	1997
DMP 266 now available. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1997, Volume: 11, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Humans; Oxazines; Reverse Transcriptase Inhibitors; Viral Load	1997
Moving forward: a treatment overview from the 12th World AIDS Conference. Newsline (People with AIDS Coalition of New York), 1998 Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Benzoxazines; Carbamates; CD4-Positive T-Lymphocytes; Clinical Trials as Topic; Congresses as Topic; Cyclopropanes; Dideoxynucleosides; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Furans; Health Services Accessibility; HIV Protease Inhibitors; Humans; Hydroxyurea; Lopinavir; Oxazines; Patient Care Planning; Pyrimidinones; Remission Induction; Reverse Transcriptase Inhibitors; Sulfonamides; Switzerland; Virus Replication	1998
Association between efavirenz and selected psychiatric and neurological conditions. The Journal of infectious diseases, 2002, Jan-15, Volume: 185, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Female; HIV-1; Humans; Male; Oxazines	2002
Virologic and immunologic response to regimens containing nevirapine or efavirenz in combination with 2 nucleoside analogues in the Italian Cohort Naive Antiretrovirals (I.Co.N.A.) study. The Journal of infectious diseases, 2002, Apr-15, Volume: 185, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Cyclopropanes; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nevirapine; Oxazines; RNA, Viral	2002